|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade receivables, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Receivables from related parties | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Current assets held for sale - discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Software, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investments in unconsolidated affiliate | ||||||||||||||||||||
| Deferred contract costs, net | ||||||||||||||||||||
| Note receivable with Parent | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Non-current assets held for sale - discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade accounts payable and other accrued liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Current portion of debt | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Current liabilities held for sale - discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Non-current liabilities held for sale - discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock; $0.0001 par value; 550,000,000 shares authorized, 160,040,598 shares issued and 155,930,399 shares outstanding as of December 31, 2022 | ||||||||||||||||||||
| Preferred stock; $0.0001 par value; 25,000,000 shares authorized; issued and outstanding, none as of December 31, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Contribution from Parent | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 4,110,199 shares as of December 31, 2022 | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interests and shareholders' equity |
Loading...
